Wedbush

Wedbush Analyst Recommendations & Stock Picks

View the latest stock recommendations issued by analysts at Wedbush. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from Wedbush's equity research team. MarketBeat is not affiliated with or endorsed by Wedbush.

Average Return
00.00% 12-Month ROI
Total Ratings
941 Last 12 Months
Buy Ratings
743 Last 12 Months
Sell Ratings
19 Last 12 Months
Companies Covered
286 Last 12 Months
MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.
Available with a MarketBeat All Access Subscription
MarketRank™Upgrade to All Access to use the All Ranks Filter
Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.
Available with a MarketBeat All Access Subscription
Media SentimentUpgrade to All Access to use the All Sentiments Filter
Analyst consensus is the average investment recommendation among Wall Street research analysts.
Available with a MarketBeat All Access Subscription
Analyst ConsensusUpgrade to All Access to use the All Ratings Filter
CompanyCurrent PriceReport DateAnalystActionPrice TargetRating12-Month Recommendation ROIDetails
Micron Technology, Inc. stock logo
MU
Micron Technology
$1,133.99
6/18/2026Boost Price Target$500.00 ➝ $1,300.00OutperformView details for Wedbush rating of Micron Technology (NASDAQ:MU) on 6/18/2026
Palantir Technologies Inc. stock logo
PLTR
Palantir Technologies
$128.47
6/16/2026Initiated CoverageOutperformView details for Wedbush rating of Palantir Technologies (NASDAQ:PLTR) on 6/16/2026
TripAdvisor, Inc. stock logo
TRIP
TripAdvisor
$12.97
6/16/2026Boost Price Target$19.00 ➝ $20.00OutperformView details for Wedbush rating of TripAdvisor (NASDAQ:TRIP) on 6/16/2026
Spyre Therapeutics, Inc. stock logo
SYRE
Spyre Therapeutics
$88.34
6/16/2026Reiterated Rating$100.00OutperformView details for Wedbush rating of Spyre Therapeutics (NASDAQ:SYRE) on 6/16/2026
Roku, Inc. stock logo
ROKU
Roku
$138.07
6/16/2026Downgrade$155.00OutperformNeutralView details for Wedbush rating of Roku (NASDAQ:ROKU) on 6/16/2026
Flutter Entertainment PLC stock logo
FLUT
Flutter Entertainment
$101.78
-0.1%
6/15/2026Initiated Coverage$138.00OutperformView details for Wedbush rating of Flutter Entertainment (NYSE:FLUT) on 6/15/2026
Datadog, Inc. stock logo
DDOG
Datadog
$223.00
6/15/2026Initiated CoverageOutperformNeutralView details for Wedbush rating of Datadog (NASDAQ:DDOG) on 6/15/2026
EPAM Systems, Inc. stock logo
EPAM
EPAM Systems
$76.37
-0.4%
6/15/2026Initiated Coverage$99.00Sector PerformNeutralView details for Wedbush rating of EPAM Systems (NYSE:EPAM) on 6/15/2026
EPAM Systems, Inc. stock logo
EPAM
EPAM Systems
$76.37
-0.4%
6/15/2026Initiated Coverage$99.00Sector PerformNeutralView details for Wedbush rating of EPAM Systems (NYSE:EPAM) on 6/15/2026
Flutter Entertainment PLC stock logo
FLUT
Flutter Entertainment
$101.78
-0.1%
6/15/2026UpgradeStrong-BuyView details for Wedbush rating of Flutter Entertainment (NYSE:FLUT) on 6/15/2026
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
$15.67
6/15/2026Reiterated Rating$12.00NeutralView details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 6/15/2026
Climb Bio, Inc. stock logo
CLYM
Climb Bio
$11.45
6/12/2026Reiterated Rating$17.00OutperformView details for Wedbush rating of Climb Bio (NASDAQ:CLYM) on 6/12/2026
Damora Therapeutics, Inc. Common Stock stock logo
DMRA
Damora Therapeutics, Inc. Common Stock
$21.23
6/12/2026Reiterated Rating$35.00OutperformView details for Wedbush rating of Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) on 6/12/2026
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
$31.23
6/12/2026Reiterated Rating$58.00OutperformView details for Wedbush rating of IDEAYA Biosciences (NASDAQ:IDYA) on 6/12/2026
Immunome, Inc. stock logo
IMNM
Immunome
$18.74
6/12/2026Reiterated Rating$31.00OutperformView details for Wedbush rating of Immunome (NASDAQ:IMNM) on 6/12/2026
Oracle Corporation stock logo
ORCL
Oracle
$184.66
+0.2%
6/11/2026Lower Price Target$275.00 ➝ $240.00OutperformView details for Wedbush rating of Oracle (NYSE:ORCL) on 6/11/2026
Oracle Corporation stock logo
ORCL
Oracle
$184.66
+0.2%
6/11/2026Lower Price Target$275.00 ➝ $240.00OutperformView details for Wedbush rating of Oracle (NYSE:ORCL) on 6/11/2026
argenex SE stock logo
ARGX
argenex
$877.72
6/11/2026Reiterated Rating$1,000.00OutperformView details for Wedbush rating of argenex (NASDAQ:ARGX) on 6/11/2026
Cullinan Therapeutics, Inc. stock logo
CGEM
Cullinan Therapeutics
$15.03
6/11/2026Reiterated Rating$37.00OutperformView details for Wedbush rating of Cullinan Therapeutics (NASDAQ:CGEM) on 6/11/2026
Rubrik, Inc. stock logo
RBRK
Rubrik
$70.28
+0.1%
6/11/2026Reiterated Rating$90.00OutperformView details for Wedbush rating of Rubrik (NYSE:RBRK) on 6/11/2026
Datadog, Inc. stock logo
DDOG
Datadog
$223.00
6/10/2026Boost Price Target$220.00 ➝ $260.00OutperformView details for Wedbush rating of Datadog (NASDAQ:DDOG) on 6/10/2026
Disc Medicine, Inc. stock logo
IRON
Disc Medicine
$70.79
6/10/2026Reiterated Rating$88.00OutperformView details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 6/10/2026
NiCE stock logo
NICE
NiCE
$84.68
6/10/2026Lower Price Target$120.00 ➝ $100.00NeutralView details for Wedbush rating of NiCE (NASDAQ:NICE) on 6/10/2026
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
$9.63
6/10/2026Reiterated Rating$38.00OutperformView details for Wedbush rating of Cartesian Therapeutics (NASDAQ:RNAC) on 6/10/2026
VinFast Auto Ltd. stock logo
VFS
VinFast Auto
$3.04
6/10/2026Reiterated Rating$6.00OutperformView details for Wedbush rating of VinFast Auto (NASDAQ:VFS) on 6/10/2026
Zscaler, Inc. stock logo
ZS
Zscaler
$124.85
6/10/2026Reiterated Rating$220.00OutperformView details for Wedbush rating of Zscaler (NASDAQ:ZS) on 6/10/2026
Nuvalent, Inc. stock logo
NUVL
Nuvalent
$123.43
6/9/2026Downgrade$125.00 ➝ $124.00OutperformNeutralView details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 6/9/2026
Crocs, Inc. stock logo
CROX
Crocs
$125.05
6/8/2026 Initiated CoverageBuyOutperformView details for Wedbush rating of Crocs (NASDAQ:CROX) on 6/8/2026
Cerebras Systems Inc. stock logo
CBRS
Cerebras Systems
$234.84
+0.1%
6/8/2026Initiated Coverage$270.00OutperformView details for Wedbush rating of Cerebras Systems (NASDAQ:CBRS) on 6/8/2026
Cerebras Systems Inc. stock logo
CBRS
Cerebras Systems
$234.84
+0.1%
6/8/2026Initiated Coverage$270.00OutperformView details for Wedbush rating of Cerebras Systems (NASDAQ:CBRS) on 6/8/2026
Cognizant Technology Solutions Corporation stock logo
CTSH
Cognizant Technology Solutions
$43.70
6/8/2026Upgrade$56.00 ➝ $70.00NeutralOutperformView details for Wedbush rating of Cognizant Technology Solutions (NASDAQ:CTSH) on 6/8/2026
Cerebras Systems Inc. stock logo
CBRS
Cerebras Systems
$234.84
+0.1%
6/8/2026Initiated Coverage$270.00OutperformView details for Wedbush rating of Cerebras Systems (NASDAQ:CBRS) on 6/8/2026
Apple Inc. stock logo
AAPL
Apple
$298.01
6/5/2026Reiterated Rating$400.00OutperformView details for Wedbush rating of Apple (NASDAQ:AAPL) on 6/5/2026
Docusign Inc. stock logo
DOCU
Docusign
$43.47
6/5/2026Lower Price Target$60.00 ➝ $58.00NeutralView details for Wedbush rating of Docusign (NASDAQ:DOCU) on 6/5/2026
Planet Labs PBC stock logo
PL
Planet Labs PBC
$28.18
-0.2%
6/5/2026Reiterated Rating$50.00OutperformView details for Wedbush rating of Planet Labs PBC (NYSE:PL) on 6/5/2026
Palantir Technologies Inc. stock logo
PLTR
Palantir Technologies
$128.47
6/5/2026Reiterated Rating$230.00OutperformView details for Wedbush rating of Palantir Technologies (NASDAQ:PLTR) on 6/5/2026
Rubrik, Inc. stock logo
RBRK
Rubrik
$70.28
+0.1%
6/5/2026Reiterated Rating$90.00OutperformView details for Wedbush rating of Rubrik (NYSE:RBRK) on 6/5/2026
C3.ai, Inc. stock logo
AI
C3.ai
$10.31
+0.0%
6/4/2026Reiterated Rating$15.00OutperformView details for Wedbush rating of C3.ai (NYSE:AI) on 6/4/2026
argenex SE stock logo
ARGX
argenex
$877.72
6/4/2026Reiterated Rating$1,000.00OutperformView details for Wedbush rating of argenex (NASDAQ:ARGX) on 6/4/2026
CrowdStrike stock logo
CRWD
CrowdStrike
$684.86
6/4/2026Boost Price Target$700.00 ➝ $720.00OutperformView details for Wedbush rating of CrowdStrike (NASDAQ:CRWD) on 6/4/2026
Read now. Do not delete. You’ve been warned. (Ad)

Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.tc pixel

Don’t be left behind. Click here now.
Innodata Inc. stock logo
INOD
Innodata
$95.38
-0.1%
6/4/2026Boost Price Target$100.00 ➝ $120.00OutperformView details for Wedbush rating of Innodata (NASDAQ:INOD) on 6/4/2026
Palo Alto Networks, Inc. stock logo
PANW
Palo Alto Networks
$287.78
6/3/2026Boost Price Target$300.00 ➝ $340.00OutperformView details for Wedbush rating of Palo Alto Networks (NASDAQ:PANW) on 6/3/2026
Rezolute, Inc. stock logo
RZLT
Rezolute
$5.02
6/3/2026Boost Price Target$5.00 ➝ $6.00OutperformView details for Wedbush rating of Rezolute (NASDAQ:RZLT) on 6/3/2026
Travere Therapeutics, Inc. stock logo
TVTX
Travere Therapeutics
$55.15
6/3/2026Reiterated Rating$55.00OutperformView details for Wedbush rating of Travere Therapeutics (NASDAQ:TVTX) on 6/3/2026
Meta Platforms, Inc. stock logo
META
Meta Platforms
$577.22
6/2/2026 UpgradeOutperformNeutralView details for Wedbush rating of Meta Platforms (NASDAQ:META) on 6/2/2026
International Business Machines Corporation stock logo
IBM
International Business Machines
$249.72
+0.2%
6/2/2026Set Price Target$350.00View details for Wedbush rating of International Business Machines (NYSE:IBM) on 6/2/2026
TripAdvisor, Inc. stock logo
TRIP
TripAdvisor
$12.97
6/2/2026Initiated Coverage$19.00NeutralOutperformView details for Wedbush rating of TripAdvisor (NASDAQ:TRIP) on 6/2/2026
Abivax SA Sponsored ADR stock logo
ABVX
Abivax
$99.15
6/2/2026Upgrade$110.00 ➝ $90.00UnderperformNeutralView details for Wedbush rating of Abivax (NASDAQ:ABVX) on 6/2/2026
IDEAYA Biosciences, Inc. stock logo
IDYA
IDEAYA Biosciences
$31.23
6/2/2026Reiterated Rating$58.00OutperformView details for Wedbush rating of IDEAYA Biosciences (NASDAQ:IDYA) on 6/2/2026
Jade Biosciences, Inc. stock logo
JBIO
Jade Biosciences
$16.82
6/2/2026Boost Price Target$34.00 ➝ $45.00OutperformView details for Wedbush rating of Jade Biosciences (NASDAQ:JBIO) on 6/2/2026
ODTX
Odyssey Therapeutics
$19.07
6/2/2026Initiated Coverage$30.00OutperformView details for Wedbush rating of Odyssey Therapeutics (NASDAQ:ODTX) on 6/2/2026
Praxis Precision Medicines, Inc. stock logo
PRAX
Praxis Precision Medicines
$282.31
6/2/2026Lower Price Target$166.00 ➝ $162.00UnderperformView details for Wedbush rating of Praxis Precision Medicines (NASDAQ:PRAX) on 6/2/2026
TripAdvisor, Inc. stock logo
TRIP
TripAdvisor
$12.97
6/2/2026Initiated Coverage$19.00NeutralOutperformView details for Wedbush rating of TripAdvisor (NASDAQ:TRIP) on 6/2/2026
Edgewise Therapeutics, Inc. stock logo
EWTX
Edgewise Therapeutics
$36.87
+0.2%
6/1/2026Boost Price Target$46.00 ➝ $52.00OutperformView details for Wedbush rating of Edgewise Therapeutics (NASDAQ:EWTX) on 6/1/2026
Revolution Medicines, Inc. stock logo
RVMD
Revolution Medicines
$162.99
6/1/2026Reiterated RatingOutperformView details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 6/1/2026
Replimune Group, Inc. stock logo
REPL
Replimune Group
$10.19
6/1/2026Boost Price Target$2.00 ➝ $6.00NeutralView details for Wedbush rating of Replimune Group (NASDAQ:REPL) on 6/1/2026
Dycom Industries, Inc. stock logo
DY
Dycom Industries
$456.23
-0.1%
5/29/2026 Set Price Target$654.00View details for Wedbush rating of Dycom Industries (NYSE:DY) on 5/29/2026
Voyager Technologies, Inc. stock logo
VOYG
Voyager Technologies
$37.61
+0.1%
5/29/2026Boost Price Target$46.00 ➝ $60.00OutperformView details for Wedbush rating of Voyager Technologies (NYSE:VOYG) on 5/29/2026
Okta, Inc. stock logo
OKTA
Okta
$117.81
5/29/2026 Reiterated Rating$60.00OutperformView details for Wedbush rating of Okta (NASDAQ:OKTA) on 5/29/2026
Best Buy Co., Inc. stock logo
BBY
Best Buy
$74.89
+0.2%
5/29/2026Boost Price Target$70.00 ➝ $75.00NeutralView details for Wedbush rating of Best Buy (NYSE:BBY) on 5/29/2026
Cogent Biosciences, Inc. stock logo
COGT
Cogent Biosciences
$34.54
5/29/2026Reiterated Rating$55.00OutperformView details for Wedbush rating of Cogent Biosciences (NASDAQ:COGT) on 5/29/2026
Elastic N.V. stock logo
ESTC
Elastic
$58.89
-0.1%
5/29/2026Lower Price Target$74.00 ➝ $65.00OutperformView details for Wedbush rating of Elastic (NYSE:ESTC) on 5/29/2026
International Business Machines Corporation stock logo
IBM
International Business Machines
$249.72
+0.2%
5/29/2026Reiterated Rating$320.00OutperformView details for Wedbush rating of International Business Machines (NYSE:IBM) on 5/29/2026
MongoDB, Inc. stock logo
MDB
MongoDB
$332.75
5/29/2026Boost Price Target$380.00 ➝ $390.00OutperformView details for Wedbush rating of MongoDB (NASDAQ:MDB) on 5/29/2026
NetApp, Inc. stock logo
NTAP
NetApp
$159.71
5/29/2026Boost Price Target$115.00 ➝ $150.00NeutralView details for Wedbush rating of NetApp (NASDAQ:NTAP) on 5/29/2026
SentinelOne, Inc. stock logo
S
SentinelOne
$15.01
-0.1%
5/29/2026Reiterated Rating$20.00OutperformView details for Wedbush rating of SentinelOne (NYSE:S) on 5/29/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$29.12
5/29/2026Reiterated Rating$40.00OutperformView details for Wedbush rating of STAAR Surgical (NASDAQ:STAA) on 5/29/2026
Everpure, Inc. stock logo
P
Everpure
$74.73
+0.2%
5/28/2026Boost Price Target$100.00 ➝ $105.00OutperformView details for Wedbush rating of Everpure (NYSE:P) on 5/28/2026
Snowflake Inc. stock logo
SNOW
Snowflake
$232.49
+0.1%
5/28/2026Boost Price Target$270.00 ➝ $280.00OutperformView details for Wedbush rating of Snowflake (NYSE:SNOW) on 5/28/2026
Salesforce Inc. stock logo
CRM
Salesforce
$151.67
-0.1%
5/28/2026Reiterated Rating$325.00OutperformView details for Wedbush rating of Salesforce (NYSE:CRM) on 5/28/2026
Damora Therapeutics, Inc. Common Stock stock logo
DMRA
Damora Therapeutics, Inc. Common Stock
$21.23
5/28/2026Initiated Coverage$35.00OutperformView details for Wedbush rating of Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) on 5/28/2026
Nuvalent, Inc. stock logo
NUVL
Nuvalent
$123.43
5/28/2026Reiterated Rating$125.00OutperformView details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 5/28/2026
Apogee Therapeutics Inc. stock logo
APGE
Apogee Therapeutics
$90.38
5/27/2026Boost Price Target$120.00 ➝ $135.00OutperformView details for Wedbush rating of Apogee Therapeutics (NASDAQ:APGE) on 5/27/2026
Corbus Pharmaceuticals Holdings, Inc. stock logo
CRBP
Corbus Pharmaceuticals
$8.26
5/27/2026Lower Price Target$38.00 ➝ $30.00OutperformView details for Wedbush rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 5/27/2026
CrowdStrike stock logo
CRWD
CrowdStrike
$684.86
5/27/2026Boost Price Target$550.00 ➝ $700.00OutperformView details for Wedbush rating of CrowdStrike (NASDAQ:CRWD) on 5/27/2026
Palo Alto Networks, Inc. stock logo
PANW
Palo Alto Networks
$287.78
5/27/2026Boost Price Target$225.00 ➝ $300.00OutperformView details for Wedbush rating of Palo Alto Networks (NASDAQ:PANW) on 5/27/2026
Cartesian Therapeutics, Inc. stock logo
RNAC
Cartesian Therapeutics
$9.63
5/27/2026Reiterated Rating$38.00OutperformView details for Wedbush rating of Cartesian Therapeutics (NASDAQ:RNAC) on 5/27/2026
Zscaler, Inc. stock logo
ZS
Zscaler
$124.85
5/27/2026Lower Price Target$300.00 ➝ $220.00OutperformView details for Wedbush rating of Zscaler (NASDAQ:ZS) on 5/27/2026
Oklo Inc. stock logo
OKLO
Oklo
$61.15
0.0%
5/26/2026Reiterated Rating$110.00OutperformView details for Wedbush rating of Oklo (NYSE:OKLO) on 5/26/2026
Tenable Holdings, Inc. stock logo
TENB
Tenable
$26.87
5/26/2026Reiterated Rating$29.00OutperformView details for Wedbush rating of Tenable (NASDAQ:TENB) on 5/26/2026
Hemab Therapeutics Holdings, Inc. stock logo
COAG
Hemab Therapeutics
$29.24
5/26/2026Initiated Coverage$42.00OutperformView details for Wedbush rating of Hemab Therapeutics (NASDAQ:COAG) on 5/26/2026
International Business Machines Corporation stock logo
IBM
International Business Machines
$249.72
+0.2%
5/21/2026Reiterated RatingOutperformView details for Wedbush rating of International Business Machines (NYSE:IBM) on 5/21/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
$210.69
5/21/2026Boost Price Target$300.00 ➝ $330.00OutperformView details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 5/21/2026
Globant S.A. stock logo
GLOB
Globant
$30.80
+0.2%
5/18/2026Reiterated RatingOutperformView details for Wedbush rating of Globant (NYSE:GLOB) on 5/18/2026
Larimar Therapeutics, Inc. stock logo
LRMR
Larimar Therapeutics
$3.64
-0.1%
5/18/2026Lower Price Target$13.00 ➝ $12.00OutperformView details for Wedbush rating of Larimar Therapeutics (NASDAQ:LRMR) on 5/18/2026
NVIDIA Corporation stock logo
NVDA
NVIDIA
$210.69
5/18/2026Reiterated Rating$300.00BuyView details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 5/18/2026
Globant S.A. stock logo
GLOB
Globant
$30.80
+0.2%
5/15/2026Set Price Target$54.00View details for Wedbush rating of Globant (NYSE:GLOB) on 5/15/2026
Dynatrace, Inc. stock logo
DT
Dynatrace
$41.41
0.0%
5/15/2026 Set Price Target$48.00View details for Wedbush rating of Dynatrace (NYSE:DT) on 5/15/2026
Solventum Corporation stock logo
SOLV
Solventum
$75.72
+0.4%
5/15/2026Initiated Coverage$94.00OutperformView details for Wedbush rating of Solventum (NYSE:SOLV) on 5/15/2026
Starbucks Corporation stock logo
SBUX
Starbucks
$100.65
5/14/2026 Initiated CoverageNeutralOutperformView details for Wedbush rating of Starbucks (NASDAQ:SBUX) on 5/14/2026
The REAL Reason Trump is Invading Iran (Ad)

For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.tc pixel

Click here to find out what it is.
Alto Neuroscience, Inc. stock logo
ANRO
Alto Neuroscience
$22.68
-0.3%
5/14/2026Boost Price Target$21.00 ➝ $24.00NeutralView details for Wedbush rating of Alto Neuroscience (NYSE:ANRO) on 5/14/2026
Kalaris Therapeutics Inc. stock logo
KLRS
Kalaris Therapeutics
$4.72
5/14/2026Initiated Coverage$17.00OutperformView details for Wedbush rating of Kalaris Therapeutics (NASDAQ:KLRS) on 5/14/2026
Avalo Therapeutics, Inc. stock logo
AVTX
Avalo Therapeutics
$14.70
5/14/2026Lower Price Target$40.00 ➝ $34.00OutperformView details for Wedbush rating of Avalo Therapeutics (NASDAQ:AVTX) on 5/14/2026
Innodata Inc. stock logo
INOD
Innodata
$95.38
-0.1%
5/14/2026Boost Price Target$80.00 ➝ $100.00OutperformView details for Wedbush rating of Innodata (NASDAQ:INOD) on 5/14/2026
Kalaris Therapeutics Inc. stock logo
KLRS
Kalaris Therapeutics
$4.72
5/14/2026Initiated Coverage$17.00OutperformView details for Wedbush rating of Kalaris Therapeutics (NASDAQ:KLRS) on 5/14/2026
Planet Labs PBC stock logo
PL
Planet Labs PBC
$28.18
-0.2%
5/14/2026Boost Price Target$40.00 ➝ $50.00OutperformView details for Wedbush rating of Planet Labs PBC (NYSE:PL) on 5/14/2026
STAAR Surgical Company stock logo
STAA
STAAR Surgical
$29.12
5/14/2026Upgrade$26.00 ➝ $40.00NeutralOutperformView details for Wedbush rating of STAAR Surgical (NASDAQ:STAA) on 5/14/2026
Tango Therapeutics, Inc. stock logo
TNGX
Tango Therapeutics
$27.97
5/14/2026Boost Price Target$19.00 ➝ $33.00OutperformView details for Wedbush rating of Tango Therapeutics (NASDAQ:TNGX) on 5/14/2026
Tower Semiconductor Ltd. stock logo
TSEM
Tower Semiconductor
$286.74
5/14/2026Boost Price Target$140.00 ➝ $300.00NeutralView details for Wedbush rating of Tower Semiconductor (NASDAQ:TSEM) on 5/14/2026
Vor Biopharma Inc. stock logo
VOR
Vor Biopharma
$14.49
5/14/2026Boost Price Target$15.00 ➝ $18.00NeutralView details for Wedbush rating of Vor Biopharma (NASDAQ:VOR) on 5/14/2026

MarketBeat's community ratings are surveys of what our community members think about Wedbush and other research firms in the last 90 days. Vote "Outperform" if you believe Wedbush's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe Wedbush's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.
COMMUNITY RATINGS
2.7out of 5 (last 90 days)
2.7 of 5 stars
OUTPERFORM VOTES
15 Believe will outperform the market
UNDERPERFORM VOTES
13 Believe will underperform the market

Wedbush's equity research team has issued ratings on 283 companies across 14 sectors over the past 12 months, covered by 19 analysts. The Wedbush analysts below are listed by number of ratings issued in the last year.

Wedbush Stock Coverage by Sector

Wedbush concentrates its research most heavily in Medical (39.5%), Computer and Technology (27.3%) and Consumer Discretionary (7.3%). The chart below shows how Wedbush's 286 rated companies are distributed across all 14 sectors it covers.

Wedbush - Frequently Asked Questions

Wedbush's analysts currently have buy-equivalent ratings on 233 companies. Recent upgrades to buy include Flutter Entertainment, Cognizant Technology Solutions, STAAR Surgical, Sionna Therapeutics and Rezolute.

Wedbush's highest-rated analysts by MarketBeat's accuracy score include Laura Chico, Robert Driscoll and David Nierengarten. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 19 analysts at Wedbush.

Wedbush has the deepest coverage in Medical (39.5% of rated companies), Computer and Technology (27.3% of rated companies), Consumer Discretionary (7.3% of rated companies), Retail/Wholesale (6.3% of rated companies) and Finance (4.2% of rated companies).

Wedbush issued 941 ratings over the last 12 months across 286 companies — an average of roughly 78 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current Wedbush analyst actions.

A buy rating indicates the analyst expects the stock to outperform the market over the next 12 months. A hold suggests the stock will perform in line with the market. A sell rating indicates expected underperformance. Wedbush uses Outperform, Neutral, and Underperform as their equivalents.